InvestorsHub Logo
Followers 12
Posts 2336
Boards Moderated 0
Alias Born 04/20/2006

Re: None

Saturday, 02/13/2021 10:10:35 AM

Saturday, February 13, 2021 10:10:35 AM

Post# of 14953
So March is when SORRENTO sees results of the Abivertinib Futility study on 40 patients and continues forward to completion with a total of 80 patients. If this does pass this phase and goes to completion would it still have a place in the line-up or does COVI-MSC put it on the bench?